Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease.

Müller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA.

Eur J Clin Invest. 2001 Feb;31(2):131-7.

PMID:
11168451
3.

Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I, Ersoz HO.

Endocrine. 2009 Feb;35(1):75-80. doi: 10.1007/s12020-008-9116-4.

PMID:
18958631
4.

Blood coagulation and fibrinolytic activity in hypothyroidism.

Erem C, Kavgaci H, Ersöz HO, Hacihasanoglu A, Ukinç K, Karti SS, Deger O, Telatari M.

Int J Clin Pract. 2003 Mar;57(2):78-81.

PMID:
12661786
6.

Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.

Erem C, Kocak M, Hacihasanoglu A, Yilmaz M, Saglam F, Ersoz HO.

Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):619-24. doi: 10.1055/s-2008-1065365.

PMID:
18484067
7.

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.

Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L.

Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1170-6.

8.

Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism.

Chadarevian R, Jublanc C, Bruckert E, Giral P, Ankri A, Leenhardt L, Chapman J, Turpin G.

J Endocrinol Invest. 2005 May;28(5):398-404.

PMID:
16075920
9.

Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.

Kario K, Matsuo T, Kobayashi H, Matsuo M, Sakata T, Miyata T.

Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1114-20.

11.

Elevated thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels in overt and subclinical hypothyroid patients were reduced by levothyroxine replacement.

Akinci B, Comlekci A, Ali Ozcan M, Demir T, Yener S, Demirkan F, Yuksel F, Yesil S.

Endocr J. 2007 Feb;54(1):45-52.

12.

Socioeconomic status and determinants of hemostatic function in healthy women.

Wamala SP, Murray MA, Horsten M, Eriksson M, Schenck-Gustafsson K, Hamsten A, Silveira A, Orth-Gomér K.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):485-92.

13.

Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease.

He WJ, Hu Y, Zhang XP, Hong M, Guo T, Wei WN, Song SJ.

Eur J Med Res. 2008 Feb 25;13(2):47-51.

PMID:
18424361
14.

Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.

Michiels JJ, Schroyens W, Berneman Z, van der Planken M.

Clin Appl Thromb Hemost. 2001 Apr;7(2):113-5. Review.

PMID:
11292187
15.

Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis.

Schmitz-Huebner U, Thompson SG, Balleisen L, Fechtrup C, Grosse-Heitmeyer W, Kirchhof B, Most E, Müller US, Seiffert C, Seiffert D, et al.

Br Heart J. 1988 Mar;59(3):287-91.

16.

Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism.

Alturfan AA, Alturfan EE, Dariyerli N, Zengin E, Aytac E, Yigit G, Kokoglu E.

Endocrine. 2006 Aug;30(1):63-7.

PMID:
17185793
17.
18.

Congenital protein C deficiency and myocardial infarction:concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis.

Kario K, Matsuo T, Tai S, Sakamoto S, Yamada T, Miki T, Matsuo M.

Thromb Res. 1992 Jul 1;67(1):95-103.

PMID:
1440517
19.

Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.

Cugno M, Mari D, Meroni PL, Gronda E, Vicari F, Frigerio M, Coppola R, Bottasso B, Borghi MO, Gregorini L.

Br J Haematol. 2004 Jul;126(1):85-92.

PMID:
15198737
20.

Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.

Raffa S, Reverter JC, Seijo S, Tassies D, Abraldes JG, Bosch J, García-Pagán JC.

Clin Gastroenterol Hepatol. 2012 Jan;10(1):72-8. doi: 10.1016/j.cgh.2011.09.010.

PMID:
21946303
Items per page

Supplemental Content

Support Center